Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-24

Clinical Trial Update: Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C) [Phase 2]

View source ↗

Summary

Phase 2 trial update for linaclotide in irritable bowel syndrome with constipation has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Linaclotide (linaclotide)

Snippet

Sponsor: Ironwood Pharmaceuticals, Inc. | Conditions: Irritable Bowel Syndrome With Constipation | Phase 2 | Status: COMPLETED | Results posted: 2020-04-24